(CBS) – Prinston Pharmaceutical Inc. announced it is voluntarily recalling eight batches of blood pressure medication due to traces of a cancer-causing chemical. This is the latest recall in a series that began in July with the same ingredient of blood pressure medicines from various pharmaceutical companies.
Prinston recalls a batch of Irbesartan and seven batches of Irbesartan HCTZ tablets. These lots contain a chemical called N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels of the FDA.
"N-Nitrosodiethylamine (NDEA) is a substance found in certain foods, in certain foods, in drinking water, in the air and in the air, and has been identified as a probable human carcinogen according to the International Agency for Research on Cancer (IARC) classified, "the company said in a press release.
Prinston says it has received no reports of patients who have been harmed by the disease recalled products.
The drugs involved are used to combat hypertension and to treat heart failure. They have been distributed nationwide to wholesalers, resellers, repackagers and retail customers.
Patients are advised to check with their doctor or pharmacist for alternative treatment before returning their medication. Those who are currently taking irbesartan should take their medication until a pharmacist provides a replacement or the doctor prescribes another medicine to treat the same condition. Immediate discontinuation of the medication poses a higher risk without alternative treatment.
For a complete list of recalled products, visit the Prinston Web site.
Earlier this month, Aurobindo Pharma USA, Inc. announced that it would voluntarily recall 80 lots of amlodipine valsartan tablets, valsartan HCTZ tablets and valsartan tablets on similar concerns over NDEA trace levels. Since July, other drug companies including Torrent Pharmaceuticals Limited, Teva Pharmaceuticals and Mylan Pharmaceuticals have also withdrawn some of their products for the same reason.